---
layout: post
title: "Collecting and Providing 702(b) Portions of Food and Drug Administration Official Samples-Questions and Answers; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:57:47 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01143
original_published: 2022-01-21 00:00:00 +0000
significance: 8.00
---

# Collecting and Providing 702(b) Portions of Food and Drug Administration Official Samples-Questions and Answers; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 21, 2022 00:00 UTC
**Document Number:** 2022-01143

## Summary

The Food and Drug Administration (FDA or we) is announcing the availability of a draft guidance for industry and FDA staff entitled "Collecting and Providing 702(b) Portions of FDA Official Samples-- Questions and Answers." This draft guidance is intended to assist industry and FDA staff with issues and questions related to the requirements for FDA to collect and provide a part of an official sample of an article to any person named on the label of the article, or the owner thereof, or his attorney or agent.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/21/2022-01143/collecting-and-providing-702b-portions-of-food-and-drug-administration-official-samples-questions)
- API: https://www.federalregister.gov/api/v1/documents/2022-01143

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
